Cornerstone Advisory, LLC Tyme Technologies, Inc. Transaction History

Cornerstone Advisory, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 20, 2022	SELL	$0.28 - $0.68 $7 - $17	-25 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$0.6 - $1.04 $15 - $26	25 New	25 $0

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

Get notified when there are updates to the investment portfolio of Cornerstone Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Cornerstone Advisory, LLC with notifications on news.